Prosecution Insights
Last updated: October 25, 2026

Public University Corporation Nara Medical University

Technology area: Chemistry & Materials

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Public University Corporation Nara Medical University maintains a company patent portfolio with 1 pending office action. This action is classified under the Chemistry & Materials technology area. The prosecution of this matter is handled by 1 distinct examiner, indicating a single point of contact for the current pending workload. The data identifies 1 distinct art unit associated with this portfolio.

ALI, WAQAAS A is the busiest examiner for this entity, with 1 pending office action currently assigned. This examiner's 1 pending action represents the entirety of the university's current pending office actions. The 1 distinct art unit shows that the technical subject matter is being evaluated within one specific section of the patent office. This concentration suggests that the technical review is not distributed across multiple examination groups.

The 1 distinct examiner, ALI, WAQAAS A, is the only examiner listed for the 1 pending office action. This means that the prosecution of the Chemistry & Materials filings does not currently involve multiple examiners or different art units. The data reflects a portfolio with a single active office action response required at this time. Practitioners can focus their strategy on the specific requirements of the 1 art unit involved in the examination of this portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ALI, WAQAAS A 1 81.1% +17.8%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18282917 FILTER, MANUFACTURING METHOD THEREFOR, FILTER DEVICE, METHOD OF SEPARATING OR FRACTIONATING RARE CELLS, AND METHOD OF ANALYZING RARE CELLS IN CELL SUSPENSION ALI, WAQAAS A —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18282917 FILTER, MANUFACTURING METHOD THEREFOR, FILTER DEVICE, METHOD OF SEPARATING OR FRACTIONATING RARE CELLS, AND METHOD OF ANALYZING RARE CELLS IN CELL SUSPENSION ALI, WAQAAS A —

Top Art Units

Art UnitApps
1798 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18282917 FILTER, MANUFACTURING METHOD THEREFOR, FILTER DEVICE, METHOD OF SEPARATING OR FRACTIONATING RARE CELLS, AND METHOD OF ANALYZING RARE CELLS IN CELL SUSPENSION ALI, WAQAAS A 1798 §103§112 Non-Final OA — Pending Sep 19, 2023

Managing Public University Corporation Nara Medical University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Public University Corporation Nara Medical University have?

Public University Corporation Nara Medical University has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Public University Corporation Nara Medical University applications?

Waqaas A Ali has the most, with 1 of Public University Corporation Nara Medical University's pending office actions.

What technology area are Public University Corporation Nara Medical University's patent applications in?

Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month